휴대용 카프노그래피 기기 시장 : 세계 예측(2026-2032년)

The Portable Capnography Device Market is projected to grow by USD 851.38 million at a CAGR of 5.60% by 2032.

Portable Capnography Devices: Executive Summary

Portable capnography devices provide noninvasive, near-real-time measurement of exhaled carbon dioxide and respiratory rate. Their value is tied to respiratory monitoring, procedural safety, anesthesia support, emergency care, transport, and remote or resource-constrained clinical settings. Adoption depends on clinical utility, measurement reliability, workflow integration, device portability, staff training, reimbursement conditions, and applicable regulatory requirements.

Care Delivery Is Shifting Toward Portable Respiratory Monitoring

Healthcare delivery is increasingly distributed across ambulances, emergency departments, operating rooms, intensive care units, outpatient facilities, and home-based settings. This shift raises demand for compact systems that can be deployed quickly and used across varied patient populations. Clinicians are also placing greater emphasis on continuous ventilation assessment, early recognition of respiratory deterioration, and standardized monitoring during sedation and transport. Device design is therefore moving toward simpler interfaces, faster setup, improved battery performance, durable construction, and compatibility with different sampling configurations.

Artificial Intelligence Can Strengthen Interpretation and Workflow Support

Artificial intelligence can expand the practical value of portable capnography by identifying waveform changes, flagging abnormal respiratory patterns, supporting alarm prioritization, and helping clinicians review longitudinal data. Integration with electronic health records and connected monitoring platforms may reduce documentation burden and improve continuity across care settings. However, dependable deployment requires representative clinical validation, transparent performance measures, cybersecurity controls, human oversight, and clear separation between decision support and autonomous diagnosis. AI should complement, rather than replace, clinical assessment and established monitoring protocols.

Regional Conditions Shape Adoption and Clinical Use

North America is characterized by established emergency, anesthesia, and critical-care infrastructure, with adoption influenced by clinical protocols, procurement standards, interoperability, and reimbursement. Latin America presents opportunities in emergency transport, procedural care, and decentralized facilities, while affordability, training, and service availability remain important considerations. Europe benefits from mature hospital systems and cross-border regulatory alignment, with purchasing shaped by evidence, usability, sustainability, and integration requirements. The Middle East is supported by investment in advanced hospitals and emergency services, alongside a need for multilingual training and reliable technical support. Africa's use is strongly connected to transport medicine, surgery, emergency care, and resource-efficient deployment, making durability, consumables access, and workforce education central. Asia-Pacific combines advanced healthcare markets with rapidly expanding and highly diverse systems; adoption priorities include portable designs, local servicing, clinical education, and suitability for urban, rural, and mobile care environments.

Economic and Institutional Groups Reveal Distinct Priorities

ASEAN markets generally emphasize scalable equipment, workforce training, and suitability for mixed public-private healthcare systems. BRICS members span advanced and developing care environments, encouraging attention to local manufacturing capacity, procurement efficiency, affordability, and service networks. The European Union places importance on regulatory compliance, clinical evidence, interoperability, data protection, and sustainability. G7 health systems typically assess devices through rigorous safety, usability, quality-management, and workflow-integration criteria. GCC countries often prioritize advanced hospital capability, emergency readiness, and dependable supplier support. NATO members, particularly those coordinating civil and defense medical readiness, may value ruggedness, interoperability, transport use, and continuity of care across operational settings.

Country-Level Priorities Differ Across Clinical Infrastructure and Regulation

Australia's dispersed geography supports interest in portable monitoring for emergency transport, regional hospitals, and procedural care. Brazil and Mexico may benefit from devices suited to varied hospital capacity, ambulance services, and cost-sensitive procurement. Canada emphasizes use across large urban systems and remote or northern communities, where portability and serviceability matter. China and India have broad opportunities across tertiary hospitals, emergency services, and expanding regional care networks, with localization and training remaining important. France, Germany, Italy, Spain, and the United Kingdom operate within sophisticated European healthcare environments where evidence, compliance, integration, and operational efficiency influence purchasing. Japan and South Korea prioritize compact engineering, dependable performance, and integration with advanced clinical workflows. Russia's adoption context is shaped by healthcare access, domestic supply considerations, and service continuity. The United States has extensive use cases across emergency medicine, anesthesia, critical care, and transport, with purchasing influenced by clinical standards, interoperability, and regulatory expectations.

Prioritize Evidence, Workflow Fit, and Sustainable Deployment

Industry leaders should define target use cases by care setting and patient pathway before selecting device features. Product development should focus on accurate measurements, intuitive waveform presentation, reliable alarms, battery resilience, cleaning compatibility, consumables availability, and interoperability. Organizations should validate devices through clinically relevant protocols, document training requirements, and measure outcomes such as response time, usability, alarm performance, and continuity of monitoring. Commercial and procurement strategies should account for total cost of ownership, technical support, cybersecurity, regulatory obligations, and equitable access. AI-enabled functions should be introduced with prospective validation, explainable outputs, monitoring for performance drift, and explicit clinician accountability.

Methodology: Structured Synthesis of Clinical and Market-Relevant Evidence

This executive summary uses a structured qualitative approach centered on the defined portable capnography device category. The assessment organizes insights around clinical applications, technology evolution, care-delivery settings, regulatory and procurement considerations, regional conditions, economic groupings, and country-level healthcare characteristics. Conclusions are framed from established principles of respiratory monitoring, medical-device adoption, interoperability, patient safety, and implementation science. No market estimates, market shares, forecasts, or company-specific claims are used. Regional, group, and country observations are comparative context rather than quantitative rankings.

Portable Capnography's Value Depends on Reliable Integration Into Care

Portable capnography devices are positioned to support safer and more responsive respiratory monitoring across hospital, emergency, transport, procedural, and decentralized settings. The strongest implementation prospects will come from solutions that combine measurement reliability with portability, straightforward workflows, robust support, and compatibility with clinical information systems. Regional and country differences make adaptable deployment essential, while AI can add value only when validated, secure, transparent, and governed by clinicians. Leaders that connect product design with evidence, training, service continuity, and practical workflow needs will be better placed to advance safe adoption.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Portable Capnography Device Market, by Product Type

• 7.1. Introduction
• 7.2. Mainstream
• 7.3. Microstream
• 7.4. Sidestream

8. Portable Capnography Device Market, by Operation Mode

• 8.1. Introduction
• 8.2. Continuous
• 8.3. Intermittent

9. Portable Capnography Device Market, by Technology

• 9.1. Introduction
• 9.2. Integrated Monitors
  • 9.2.1. Anesthesia Machines
  • 9.2.2. Multi-Parameter Monitors
• 9.3. Standalone Monitors
  • 9.3.1. Portable Units
  • 9.3.2. Table-Top Units

10. Portable Capnography Device Market, by Application

• 10.1. Introduction
• 10.2. Home Care
  • 10.2.1. Home Health Agencies
  • 10.2.2. Personal Use
• 10.3. Inpatient
  • 10.3.1. Emergency Department
  • 10.3.2. Intensive Care Unit
  • 10.3.3. Operating Room
• 10.4. Outpatient
  • 10.4.1. Ambulatory Surgery Center
  • 10.4.2. Outpatient Clinics

11. Portable Capnography Device Market, by End User

• 11.1. Introduction
• 11.2. Ambulatory Surgery Centers
• 11.3. Clinics
• 11.4. Emergency Medical Services
• 11.5. Hospitals

12. Portable Capnography Device Market, by Distribution Channel

• 12.1. Introduction
• 12.2. Online
• 12.3. Offline

13. Portable Capnography Device Market, by Region

• 13.1. Introduction
• 13.2. Asia-Pacific
• 13.3. North America
• 13.4. Latin America
• 13.5. Europe
• 13.6. Middle East
• 13.7. Africa

14. Portable Capnography Device Market, by Group

• 14.1. Introduction
• 14.2. ASEAN
• 14.3. GCC
• 14.4. European Union
• 14.5. BRICS
• 14.6. G7
• 14.7. NATO

15. Portable Capnography Device Market, by Country

• 15.1. Introduction
• 15.2. United States
• 15.3. Canada
• 15.4. Mexico
• 15.5. Brazil
• 15.6. United Kingdom
• 15.7. Germany
• 15.8. France
• 15.9. Russia
• 15.10. Italy
• 15.11. Spain
• 15.12. China
• 15.13. India
• 15.14. Japan
• 15.15. Australia
• 15.16. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. Market Concentration Analysis, 2025
  • 16.2.1. Concentration Ratio (CR)
  • 16.2.2. Herfindahl Hirschman Index (HHI)
• 16.3. Recent Developments & Impact Analysis, 2025
• 16.4. Product Portfolio Analysis, 2025
• 16.5. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Allied Healthcare Products, Inc.
• 17.2. Ambu A/S
• 17.3. Baxter International Inc.
• 17.4. BPL Medical Technologies Private Limited
• 17.5. Invacare Corporation
• 17.6. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
• 17.7. Koninklijke Philips N.V.
• 17.8. Laerdal Medical AS
• 17.9. Medela AG
• 17.10. Medical Depot, Inc.
• 17.11. Medline Industries, LP
• 17.12. Narang Medical Limited
• 17.13. Nihon Kohden Corporation
• 17.14. Smiths Group plc
• 17.15. ZOLL Medical Corporation

18. Key Experts